2017 American Transplant Congress Archives - Page 20 of 181

6:00pm-7:00pm: A Nationwide Global Strategy for Kidney Transplantation with Controlled Cardiac Death Donor (cDCD) Has Improved Global Results. Spanish Multicentre SENTRA-GEODAS Group.

J. Portoles,^1,2 M. Perez-Saez,^2,3 D. Janeiro,^1,2 E. Melilli,² N. Maruri Kareaga,² E. de Souza,² F. Llamas,² J. Espi,² P. Martin Moreno,² D. Navarro,² A. Sancho-Calabuig,² M. Rodriguez-Ferrero,² D. Hernandez,² J. Pascual.^2,3

Poster Session C: Deceased Donor Issues II: DCD, DGF, AKI, En-Bloc • Hall D1

6:00pm-7:00pm: A Novel Method for iNKT Cell-Mediated Ex Vivo Treg Expansion Applied to Induce Human Transplant Tolerance.

H. Katsumata,^1,2 M. Ikemiyagi,¹ S. Miyairi,¹ R. Ishii,¹ T. Kanzawa,¹ H. Fukuda,¹ T. Hirai,¹ M. Okumi,¹ Y. Ishii,³ K. Tanabe.¹

Poster Session C: Tolerance/Immune Regulation • Hall D1

6:00pm-7:00pm: A Novel MyD88 Inhibitor Attenuates Allograft Rejection in Heterotopic Tracheal Transplantation in Mice.

M. Yang, X. Zhang, G. Chen, Z.-C. Ding, Y. Miao, Y. Yang, P. Zhou.

Poster Session C: Innate Immunity • Hall D1

6:00pm-7:00pm: A Novel Role for MyD88 Signaling Downstream from Toll-Like Receptors in B Cells Responding to Blood Group Antigens.

H. Sakai, Y. Tanaka, H. Ohdan.

Poster Session C: Innate Immunity • Hall D1

6:00pm-7:00pm: A Novel Technique to Increase Donor Utilization: Our Experience Using High-Dose Tissue Plasminogen Activator Flush in Donation-After-Cardiac-Death Donors for Liver Transplantation.

J. Graham, K. Lorenzen, S. Bellemare, M. Kinkhabwala, J. Rocca.

Poster Session C: Donor Management: All Organs • Hall D1

6:00pm-7:00pm: A Pilot Trial of Genotype-Guided Dosing versus Standard Clinical Dosing in Pediatric Solid Organ Transplants.

S. Min, T. Daljevic, M. Lafreniere-Roula, C. Manlhiot, N. Nalli, H. Grasemann, S. Schwartz, B. Kamath, V. Ng, R. Parekh, S. Mital.

Poster Session C: Hearts and VADS: All Topics • Hall D1

6:00pm-7:00pm: A Single Center's Experience of Direct Acting Anti-Viral Agents in HCV Positive Patients Receiving an HCV Positive Kidney.

N. Kapila,¹ B. Zervos,² B. Ismail,¹ G. Schnickel,² J. Rivas,² D. Reino,² N. Agrawal,² A. Tzakis.²

Poster Session C: Deceased Donor Issues II: DCD, DGF, AKI, En-Bloc • Hall D1

6:00pm-7:00pm: A Surge in Liver Donors After Years of Decline, Is This the Tip of the Iceberg?

A. Rana,¹ M. Goss,¹ J. Rees,² M. Kueht,¹ J. Vierling,¹ A. Mindikoglu,¹ K. Halazun,³ N. Sussman,¹ B. Kaplan,⁴ P. Wood,⁵ N. Galvan,¹ R. Cotton,¹ C. O'Mahony,¹ J. Goss.¹

Poster Session C: Organ Allocation, Meld Score, Organ Utilization, and Transplant Outcomes • Hall D1

6:00pm-7:00pm: A-Antigen (Ag)-Specific Tolerance Following A-Ag Administration to Infant Mice.

B. Motyka,¹ Y. Wang,¹ B. Lamarche,¹ I. Adam,¹ J. Pearcey,¹ K. Tao,¹ C. Cairo,² P. Cowan,³ L. West.¹

Poster Session C: Tolerance/Immune Regulation • Hall D1

6:00pm-7:00pm: ABO Incompatible Deceased Donor Renal Transplantation: Exploring the Possibilities.

M. Sypek,^1,2 R. Masterson,^1,2 P. Hughes.^1,2

Poster Session C: Deceased Donor Issues II: DCD, DGF, AKI, En-Bloc • Hall D1